Gastrointestinal, Hepato-biliary and Pancreatic Surgical Oncology

A world-renowed gastrointestinal surgeon with a strong expertise in the surgical treatment of gastrointestinal cancers and inflammatory bowel disease, Dr. Fabrizio Michelassi is the Lewis Atterbury Stimson Professor and Chairman of Surgery and Surgeon-in-Chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Michelassi has contributed new insight into the surgical treatment of pancreatic and colorectal cancers, ulcerative colitis and Crohn's disease. He has pioneered the development of new surgical techniques that ensure better outcomes and improved quality of life for patients with rectal cancer and ulcerative colitis, helping patients avoid permanent stomas and maintain urological and sexual function.  Dr. Michelassi's experience and expertise in treating Crohn's disease led him to develop a novel bowel-sparing procedure now known as the Michelassi strictureplasty, which  not only saves large amounts of bowel, but also facilitates quiescence of the acute disease affecting the diseased intestinal loops.  To learn more about the Michelassi strictureplasty, click